Allscripts' New iPad Application - Analyst Blog

By
A A A

Allscripts Healthcare Solutions ( MDRX ), a leading player in the health care information technology ("HCIT") market, reported the launch of Allscripts Wand. It provides clients of Allscripts Electronic Health/Medical Record ("EHR"/"EMR") an iPad application for frequently used features of Allscripts Enterprise and Professional offerings.

The utilization of Apple Inc.'s ( AAPL ) iPad in healthcare is growing. It is reported that a significant proportion of physicians own an iPad or compatible device, which is higher than the general population.  

The Wand holds intuitive appeal and permits comfortable usage with little assistance. Two benefits from its utilization are rapid access to data and efficient workflow. According to the company, the Allscripts Wand is intended to provide quick access to commonly used features of EHR.


The health care information technology market is competitive and price sensitive. Among others, Allscripts faces strong competition from Cerner Corp. ( CERN ), Quality Systems ( QSII ) and Athenahealth ( ATHN ).

However, optimism about the growth prospects of select HCIT service providers remains high under the Obama Administration, which passed the Stimulus package in May 2009, aimed at increasing the use of electronic health record systems by medical practitioners.

The company has widened its user base after its mergers with Misys and Eclipsys and increased cross-selling opportunities.  We believe that Allscripts is well positioned in the fast growing business of selling EHR/EMR to physician practices as well as inpatient settings.

The acquisition of Eclipsys provides the company with an acute care product for sale in concert with its ambulatory services. We opine that acute and ambulatory care will continue to converge in future and that Allscripts is well positioned to provide integrated clinical applications that will permit health care providers to satisfy HITECH Act requirements and eventually comply with an outcomes-based reimbursement system. 

Strong bookings currently taking place, with both ambulatory and acute products doing well, may indicate that the Eclipsys products are popular in the market and that cross-selling synergies are for real.


 
ATHENAHEALTH IN ( ATHN ): Free Stock Analysis Report
 
CERNER CORP ( CERN ): Free Stock Analysis Report
 
ALLSCRIPTS HLTH ( MDRX ): Free Stock Analysis Report
 
QUALITY SYS ( QSII ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: ATHN , CERN , MDRX , QSII

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com